— e.g. “台裕化學製藥廠股份有限公司表示，因生產問題目前控貨中，預計115年10月中旬恢復正常供應。” (Taiwan)
product discontinuation — e.g. “Discontinuation of the manufacture of the drug” (United States)
Frequently asked questions
Is Neostigmine Methylsulfate currently in shortage?
Yes. As of the latest regulator updates, Neostigmine Methylsulfate has 3 active shortage notices across 2 countries (United States, Taiwan). Status is refreshed daily from official regulatory sources.
Why is Neostigmine Methylsulfate in shortage?
Regulators attribute the current Neostigmine Methylsulfate shortages to manufacturing problems, product discontinuation. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Neostigmine Methylsulfate shortage be resolved?
Regulator-estimated resolution dates currently range from 31 Oct 2026 to 31 Oct 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Neostigmine Methylsulfate shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Neostigmine Methylsulfate status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.